Patent foramen ovale and migraine

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 1, 2007, Pages 9-14

  Post, M C ^a   Luermans, J G L M ^a   Plokker, H W M ^a   Budts, W ^b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cardiac interatrial septum; Catheterization; Headache

Indexed keywords

CLINICAL TRIAL; DISEASE ASSOCIATION; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART RIGHT LEFT SHUNT; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MIGRAINE; MIGRAINE WITH AURA; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SOCIAL BEHAVIOR;

HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MIGRAINE DISORDERS; MIGRAINE WITH AURA; PREVALENCE;

EID: 33846007678     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20931     Document Type: Review

References (43)

1. Silberstein SD. Migraine. Lancet 2004;363:381-391.
2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
3. Schroeckenstein RF, Wasenda GJ, Edwards JE. Valvular competent patent foramen ovale in adults. Minn Med 1972;55:11-13.
4. Wilmshurst P, Nightingale S. Relationship between migraine and cardiac and pulmonary right-to-left shunts. Clin Sci (Lond) 2001; 100:215-220.
5. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
6. Godart F, Rey C, Prat A, Vincentelli A, Chmait A, Francart C, et al. Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J 2000;21: 483-489.
7. Wilmshurst PT, Byrne JC, Webb-Peploe MM. Relation between interatrial shunts and decompression sickness in divers. Lancet 1989;2:1302-1306.
8. Shanoudy H, Soliman A, Raggi P, Liu JW, Russell DC, Jarmukli NF. Prevalence of patent foramen ovale and its contribution to hypoxemia in patients with obstructive sleep apnea. Chest 1998;113: 91-96.
9. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):9-160.
10. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994;44(6 Suppl 4): S17-S23.
11. Lusic I. Population variation in migraine prevalence-the unsolved problem. Coll Antropol 2001;25:695-701.
12. Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R. A nationwide survey of migraine in France: Prevalence and clinical features in adults. GRIM. Cephalalgia 1992;12:229-237.
13. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 1999;53:537-542.
14. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
15. Olesen J, Friberg L, Olsen TS, Iversen HK, Lassen NA, Andersen AR, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798.
16. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352.
17. Dalla VG, Guindani M, Zavarise P, Griffini S, Pezzini A, Padovani A. Prevalence of patent foramen ovale in a large series of patients with migraine with aura, migraine without aura and cluster headache, and relationship with clinical phenotype. J Headache Pain 2005;6:328-330.
18. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: A case-control study. Cerebrovasc Dis 1998;8:327-330.
19. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla VG. Potential source of cerebral embolism in migraine with aura: A transcranial Doppler study. Neurology 1999;52:1622-1625.
20. Schwerzmann M, Nedeltchev K, Lagger F, Mattle HP, Windecker S, Meier B, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura. Neurology 2005;65:1415-1418.
21. Sztajzel R, Genoud D, Roth S, Mermillod B, Floch-Rohr J. Patent foramen ovale, a possible cause of symptomatic migraine: A study of 74 patients with acute ischemic stroke. Cerebrovasc Dis 2002;13:102-106.
22. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology 2004;62:1439, 1440.
23. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, et al. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495.
24. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet 2000;356:1648-1651.
25. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: Impact of transcatheter closure. J Am Coll Cardiol 2005;45:489-492.
26. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovale: A new migraine treatment? J Interv Cardiol 2003;16:39-42.
27. Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M, et al. Transcatheter patent foramen ovalc closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922-925.
28. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A. Seiler C, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;62: 1399-1401.
29. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: A case-control study. Stroke 2006;37:430-434.
30. Dowson AJ, Wilmshurst P, Muir KW, Mullen M, Nightingale S. A prospective, multicenter, randomized, double blind, placebo-controlled trial to evaluate the efficacy of patent foramen ovale closure with the STARFlex septal repair implant to prevent refractory migraine headaches: The MIST trial: S61.002. Neurology 2006;67:185.
31. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, et al. Headache, cerebrovascular symptoms, and stroke: The atherosclerosis risk in communities study. Neurology 2005;64:1573-1577.
32. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, et al. Migraine, headache, and the risk of stroke in women: A prospective study. Neurology 2005;64:1020-1026.
33. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
34. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
35. Zeller JA, Frahm K, Baron R, Stingele R, Deuschl G. Platelet-leukocyte interaction and platelet activation in migraine: A link to ischemic stroke? J Neurol Neurosurg Psychiatr 2004;75:984-987.
36. Mortelmans K, Post M, Thijs V, Herroelen L, Budts W. The influence of percutaneous atrial septal defect closure on the occurrence of migraine. Eur Heart J 2005;26:1533-1537.
37. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart 2005;91: 1173-1175.
38. Wilmshurst P, Nightingale S. The role of cardiac and pulmonary pathology in migraine: A hypothesis. Headache 2006;46:429-434.
39. Fragoso YD. Reduction of migraine attacks during the use of warfarin. Headache 1997;37:667, 668.
40. Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN. Aspirin is efficacious for the treatment of acute migraine. Headache 2005;45:283-292.
41. Bateman DN. Triptans and migraine. Lancet 2000;355:860, 861.
42. Wilmshurst PT, Pearson MJ, Nightingale S, Walsh KP, Morrison WL. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-1320.
43. Yankovsky AE, Kuritzky A. Transformation into daily migraine with aura following transcutaneous atrial septal defect closure. Headache 2003;43:496-498.